JANIX
Price
$29.66
Change
+$0.91 (+3.17%)
Updated
Jun 11 closing price
Net Assets
5.74B
WCMNX
Price
$15.04
Change
+$0.08 (+0.53%)
Updated
Jun 12 closing price
Net Assets
53.25M
Interact to see
Advertisement

JANIX vs WCMNX

Header iconJANIX vs WCMNX Comparison
Open Charts JANIX vs WCMNXBanner chart's image
JANIX vs WCMNX Comparison Chart in %
View a ticker or compare two or three
VS
JANIX vs. WCMNX commentary
Jun 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JANIX is a StrongBuy and WCMNX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JANIX has more cash in the bank: 5.74B vs. WCMNX (53.2M). JANIX (0.00) and WCMNX (0.00) have matching dividends . JANIX was incepted earlier than WCMNX: JANIX (21 years) vs WCMNX (7 years). WCMNX (2.04) is less costly to investors than JANIX (0.79). WCMNX is a more actively managed with annual turnover of: 89.00 vs. JANIX (20.00). WCMNX has a lower initial minimum investment than JANIX: WCMNX (1000) vs JANIX (2500). WCMNX annual gain was more profitable for investors over the last year : 27.46 vs. JANIX (11.42). WCMNX return over 5 years is better than : -2.34 vs. JANIX (-26.67).
JANIXWCMNXJANIX / WCMNX
Total Expense Ratio0.791.2464%
Annual Report Gross Expense Ratio0.792.0439%
Fund Existence21 years7 years-
Gain YTD12.43410.996113%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets5.74B53.2M10,788%
Annual Yield % from dividends0.000.00-
Returns for 1 year11.4227.4642%
Returns for 3 years11.2529.8838%
Returns for 5 years-26.67-2.341,141%
Returns for 10 years30.49N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALK47.320.66
+1.41%
Alaska Air Group
ROST240.131.02
+0.43%
Ross Stores
UONE5.700.01
+0.18%
Urban One Inc.
VLN2.21N/A
N/A
Valens Semiconductor Ltd
XERS6.79-0.14
-2.02%
Xeris Biopharma Holdings